Total Elbow Arthroplasty (TEA) has transitioned from a salvage procedure for severe rheumatoid arthritis to an advanced clinical intervention for complex acute distal humerus fractures, post-traumatic osteoarthritis, and unstable joint revisions. Designing elbow replacement implants demands deep understanding of ulnohumeral kinematics, rotational axes, and mechanical load-bearing. As a dedicated orthopedic manufacturer, Synoviq Medical Technology ensures each component replicates the natural biomechanics of the human elbow.
Our commitment to CE certified manufacturing guarantees that materials meet international biocompatibility criteria (ISO 10993) and possess the fatigue strength needed to withstand mechanical loading. By leveraging medical-grade titanium (Ti6Al4V) and cobalt-chromium alloys combined with ultra-high-molecular-weight polyethylene (UHMWPE) articulating surfaces, our implants minimize wear debris and reduce aseptic loosening risks.
A premier Chinese manufacturer and global exporter of high-precision orthopedic implants and surgical instruments. Synoviq delivers comprehensive OEM and ODM solutions backed by 14 years of industry expertise and rigorous ISO standards.
| Core Capability Indicator | Enterprise Specifications & Quality Standards |
|---|---|
| Company Name | Synoviq Medical Technology (China) Co., Ltd. |
| Brand Identification | Synoviq |
| Date of Establishment | March 18, 2016 (With 14 Years of Combined Team Medical Industry Experience) |
| Production Area | 18,600 m² Advanced Cleanroom & Manufacturing Facilities |
| Annual Export Volume | USD 21.8 Million |
| Overseas Market Presence | Europe, North America, South America, Middle East, Southeast Asia |
| Quality Inspection Protocols | 100% Final Inspection, Non-Destructive Testing, & Strict Raw Material Traceability |
| Regulatory Validations | CMM Measurement, Tensile Strength Testing, Surface Roughness Testing, Hardness Testing, Salt Spray Corrosion Resistance, and Sterility Validation |
| Dedicated QA/QC Personnel | 48 Specialists |
| R&D Strength | 76 In-House R&D Engineers; 186 New Innovative Products Released Annually |
| B2B Partnerships | 1,120+ Global Hospital Systems, Importers, and OEM/ODM Medical Brands |
Our state-of-the-art facility integrates advanced metallurgy, robotic CNC machining, and comprehensive physical testing to produce high-performance implants that meet stringent clinical standards.
Why global medical brands and hospital networks choose Synoviq Medical Technology for B2B orthopedics sourcing.
Our production lines adhere to CE, ISO 13485, and MDD/MDR standards. We maintain absolute compliance throughout our testing workflows, validating each chemical batch and mechanical prototype.
Based in China's advanced manufacturing hubs, we benefit from a streamlined raw material supply chain. This enables us to source medical-grade titanium and specialized tooling at competitive rates, passing the savings to our partners.
With 76 R&D engineers, we customize implant geometry, stem lengths, and instrumentation sets to match regional anatomical differences and surgical preferences.
The global joint replacement sector is moving toward personalized treatments and enhanced osseointegration. As a leading manufacturer, Synoviq integrates these scientific advancements into our product pipeline:
By mimicking natural cancellous bone, 3D-printed titanium structures allow direct bone ingrowth. This additive manufacturing technology optimizes long-term fixation of the humeral and ulnar stems, reducing reliance on bone cement (polymethyl methacrylate) and lowering the risk of stress shielding.
Wear of the polyethylene bearing insert is a primary factor in joint implant degradation. Infusing Vitamin E into HXLPE improves oxidation resistance and preserves mechanical properties, extending the operational life of the elbow prosthesis.
Sputtering HA or porous titanium coatings onto the stem surfaces speeds up bone attachment. This ensures strong primary stability and maintains consistent secondary stability, allowing patients to begin rehabilitation sooner.
Our implants are engineered to address specific orthopedic challenges and clinical presentations.
For elderly patients with osteoporotic bone, internal fixation can sometimes fail. Our semi-constrained elbow implants offer an alternative primary treatment, allowing immediate mobilization and preventing joint stiffness.
Inflammatory arthritis can erode articular cartilage and cause joint instability. Our anatomical unconstrained and linked designs replace worn surfaces while preserving the surrounding ligament structures.
When implants loosen or fail, revision surgery requires custom stems and modular components. Synoviq provides custom-length implants and specialized instrument kits to handle bone loss during revision cases.
Sourcing orthopedic implants internationally requires careful attention to regulatory compliance, supply chain security, and quality assurance. Synoviq works with medical brands, national distributors, and hospital procurement agencies to ensure smooth integration:
We work closely with medical device brands to offer tailored manufacturing services:
We create specialized surgical guides and instruments that match your implant designs, streamlining the operating workflow.
We offer plasma-sprayed titanium coatings, double-layer hydroxyapatite (HA) treatments, or micro-rough blasting to meet your specifications.
We provide technical dossiers, physical test reports, and factory audits to assist with local regulatory submissions.
Synoviq Medical
